| Scientists Now Saying the Secret to America's Happiness Is THIS (ad) |
|
| Forbes mag says this strategy "like finding money in the street" (ad) |
And Reuters magazine calls this type of trading "the new baby boomer hobby." An anonymous trader -- living at the base of the Smoky Mountains -- just released a free report revealing a step-by-step system to generating an extra $5,000 per month in income thanks to this trading strategy. The report is free until Sunday.
Click here for the FREE REPORT... |
|
You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. - American Assets Trust (NYSE:AAT) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $42.00 price target on the stock.This represents a 18.0% upside from the current price of $35.58. Read More.
- American Well (NYSE:AMWL) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $15.00 price target on the stock.This represents a 29.1% upside from the current price of $11.62. Read More.
- Credicorp (NYSE:BAP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $171.00 price target on the stock, down previously from $174.00.This represents a 29.1% upside from the current price of $132.47. Read More.
- Banco Santander México, S.A., Institución de Banca Múltiple, Grupo Financiero Santander México (NYSE:BSMX) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $6.50 price target on the stock.This represents a 11.1% upside from the current price of $5.85. Read More.
- Beyond Meat (NASDAQ:BYND) was upgraded by analysts at Sanford C. Bernstein from an "underperform" rating to an "outperform" rating. They now have a $130.00 price target on the stock.This represents a 12.5% upside from the current price of $115.52. Read More.
- Coca-Cola Europacific Partners (NYSE:CCEP) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "buy" rating. They now have a $75.00 price target on the stock.This represents a 22.4% upside from the current price of $61.28. Read More.
- Compagnie Financière Richemont (OTCMKTS:CFRUY) was upgraded by analysts at Societe Generale from a "hold" rating to a "buy" rating.The current price is $11.00. Read More.
- Cummins (NYSE:CMI) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $325.00 price target on the stock.This represents a 26.7% upside from the current price of $256.57. Read More.
- Canadian National Railway (NYSE:CNI) (TSE:CNR) was upgraded by analysts at Vertical Research from a "hold" rating to a "buy" rating.The current price is $103.25. Read More.
- CenterPoint Energy (NYSE:CNP) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $27.00 price target on the stock.This represents a 8.4% upside from the current price of $24.90. Read More.
- Cerence (NASDAQ:CRNC) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $125.00 price target on the stock.This represents a 42.4% upside from the current price of $87.80. Read More.
- Cairn Energy (OTCMKTS:CRNCY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.The current price is $4.70. Read More.
- Investors Real Estate Trust (NYSE:CSR) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating. They now have a $74.00 price target on the stock.This represents a 4.2% upside from the current price of $71.00. Read More.
- Domino's Pizza Enterprises (OTCMKTS:DMZPY) was upgraded by analysts at Citigroup Inc. from a "sell" rating to a "neutral" rating.The current price is $40.77. Read More.
- Domino's Pizza Enterprises (OTCMKTS:DMZPY) was upgraded by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from a "sell" rating to a "neutral" rating.The current price is $40.77. Read More.
- Dino Polska (OTCMKTS:DNOPY) was upgraded by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from a "neutral" rating to a "buy" rating.The current price is $32.75. Read More.
- Dino Polska (OTCMKTS:DNOPY) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.The current price is $32.75. Read More.
- Euronext (OTCMKTS:EUXTF) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.The current price is $102.72. Read More.
- GDS (NASDAQ:GDS) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "sell" rating to a "hold" rating.The current price is $72.54. Read More.
- The Gap (NYSE:GPS) was upgraded by analysts at Credit Suisse Group AG from an "underperform" rating to a "neutral" rating.The current price is $32.56. Read More.
- H & M Hennes & Mauritz AB (publ) (OTCMKTS:HNNMY) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating.The current price is $5.07. Read More.
- HP (NYSE:HPQ) was upgraded by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from a "neutral" rating to a "buy" rating. They now have a $40.00 price target on the stock, up previously from $29.00.This represents a 23.8% upside from the current price of $32.31. Read More.
- HP (NYSE:HPQ) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.The current price is $32.31. Read More.
- iQIYI (NASDAQ:IQ) was upgraded by analysts at CLSA from an "underperform" rating to an "outperform" rating. They now have a $16.00 price target on the stock, down previously from $25.50.This represents a 15.7% upside from the current price of $13.83. Read More.
- iQIYI (NASDAQ:IQ) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.The current price is $13.83. Read More.
- Kosmos Energy (NYSE:KOS) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $3.70 price target on the stock, up previously from $3.50.This represents a 19.4% upside from the current price of $3.10. Read More.
- Linde (NYSE:LIN) was upgraded by analysts at Vertical Research from a "hold" rating to a "buy" rating. They now have a $330.00 price target on the stock.This represents a 9.1% upside from the current price of $302.37. Read More.
- Alliant Energy (NASDAQ:LNT) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $61.00 price target on the stock, up previously from $50.00.This represents a 4.8% upside from the current price of $58.20. Read More.
- Mastercard (NYSE:MA) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to an "outperform" rating. They now have a $402.00 price target on the stock.This represents a 8.1% upside from the current price of $372.00. Read More.
- MediaAlpha (NYSE:MAX) was upgraded by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from a "neutral" rating to a "buy" rating. They now have a $45.00 price target on the stock, down previously from $62.00.This represents a 14.9% upside from the current price of $39.17. Read More.
- MGM Resorts International (NYSE:MGM) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $47.00 price target on the stock.This represents a 14.2% upside from the current price of $41.16. Read More.
- MorphoSys (NASDAQ:MOR) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $28.00 price target on the stock.This represents a 25.6% upside from the current price of $22.30. Read More.
- Nutrien (NYSE:NTR) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $68.00 price target on the stock, up previously from $60.00.This represents a 11.9% upside from the current price of $60.77. Read More.
- Ollie's Bargain Outlet (NASDAQ:OLLI) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $85.00 price target on the stock, up previously from $80.00.This represents a 9.0% upside from the current price of $77.95. Read More.
- Olin (NYSE:OLN) was upgraded by analysts at Vertical Research from a "hold" rating to a "buy" rating. They now have a $53.00 price target on the stock.This represents a 10.7% upside from the current price of $47.86. Read More.
- Occidental Petroleum (NYSE:OXY) was upgraded by analysts at Societe Generale from a "hold" rating to a "buy" rating. They now have a $30.00 price target on the stock.This represents a 18.8% upside from the current price of $25.26. Read More.
- Pan American Silver (NASDAQ:PAAS) (TSE:PAAS) was upgraded by analysts at National Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $48.00 price target on the stock, down previously from $50.00.This represents a 41.6% upside from the current price of $33.90. Read More.
- Public Service Enterprise Group (NYSE:PEG) was upgraded by analysts at Seaport Global Securities from a "neutral" rating to a "buy" rating. They now have a $70.00 price target on the stock.This represents a 10.0% upside from the current price of $63.65. Read More.
- The Children's Place (NASDAQ:PLCE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $150.00 price target on the stock, up previously from $48.00.This represents a 59.4% upside from the current price of $94.12. Read More.
- Shoals Technologies Group (NASDAQ:SHLS) was upgraded by analysts at Credit Suisse Group AG from a "neutral" rating to an "outperform" rating. They now have a $40.00 price target on the stock.This represents a 61.9% upside from the current price of $24.70. Read More.
- SiteOne Landscape Supply (NYSE:SITE) was upgraded by analysts at Berenberg Bank from a "hold" rating to a "buy" rating. They now have a $207.00 price target on the stock.This represents a 17.9% upside from the current price of $175.53. Read More.
- Snowflake (NYSE:SNOW) was upgraded by analysts at Rosenblatt Securities from a "neutral" rating to a "buy" rating.The current price is $233.88. Read More.
- Virgin Galactic (NYSE:SPCE) was upgraded by analysts at Alembic Global Advisors from a "neutral" rating to an "overweight" rating.The current price is $23.80. Read More.
- Systemax (NYSE:SYX) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $44.00 price target on the stock.This represents a 30.6% upside from the current price of $33.69. Read More.
- Trip.com Group (NASDAQ:TCOM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $50.00 price target on the stock.This represents a 27.3% upside from the current price of $39.27. Read More.
- thyssenkrupp (OTCMKTS:TKAMY) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating.The current price is $11.70. Read More.
- Texas Roadhouse (NASDAQ:TXRH) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.The current price is $98.94. Read More.
- UniCredit (OTCMKTS:UNCFF) was upgraded by analysts at Berenberg Bank from a "hold" rating to a "buy" rating.The current price is $13.00. Read More.
- Visa (NYSE:V) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to an "outperform" rating. They now have a $259.00 price target on the stock.This represents a 12.9% upside from the current price of $229.31. Read More.
- Wharf (OTCMKTS:WARFY) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.The current price is $6.21. Read More.
- The Williams Companies (NYSE:WMB) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $30.00 price target on the stock.This represents a 13.6% upside from the current price of $26.40. Read More.
- View today's most recent analysts' upgrades at MarketBeat.com
| The Sector Needed Change. And This Is It. (ad) |
A game changing product is helping smokers leave nicotine and tobacco completely behind!
Continue Reading |
|
- Apollo Investment (NASDAQ:AINV) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $13.75 price target on the stock, down previously from $14.50. They noted that the move was a valuation call.This represents a 0.4% upside from the current price of $13.70. Read More.
- Britvic (OTCMKTS:BTVCF) was downgraded by analysts at Societe Generale from a "buy" rating to a "hold" rating.The current price is $13.50. Read More.
- Campbell Soup (NYSE:CPB) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $54.00 price target on the stock.This represents a 10.8% upside from the current price of $48.75. Read More.
- Dollar General (NYSE:DG) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $190.00 price target on the stock.This represents a 4.8% downside from the current price of $199.59. Read More.
- Discovery (NASDAQ:DISCA) was downgraded by analysts at Moffett Nathanson from a "buy" rating to a "neutral" rating. They now have a $37.00 price target on the stock, down previously from $51.00.This represents a 16.6% upside from the current price of $31.72. Read More.
- FirstCash (NASDAQ:FCFS) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating.The current price is $79.59. Read More.
- Melco Resorts & Entertainment (NASDAQ:MLCO) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $17.00 price target on the stock.This represents a 1.6% downside from the current price of $17.27. Read More.
- The Mosaic (NYSE:MOS) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating. They now have a $37.00 price target on the stock, up previously from $32.00.This represents a 3.8% upside from the current price of $35.63. Read More.
- Marfrig Global Foods (OTCMKTS:MRRTY) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.The current price is $3.41. Read More.
- Proofpoint (NASDAQ:PFPT) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $176.00 price target on the stock.This represents a 2.8% upside from the current price of $171.19. Read More.
- View today's most recent analysts' downgrades at MarketBeat.com
| The Company Thats Disrupting The Meat Industry! (ad) |
This emerging company is setting a global mega-trend in the plant based meat area!
Continue Reading |
|
- Adicet Bio (NASDAQ:ACET) is now covered by analysts at BTIG Research. They set a "buy" rating and a $34.00 price target on the stock.This represents a 133.8% upside from the current price of $14.54. Read More.
- Agiliti (NYSE:AGTI) is now covered by analysts at Raymond James. They set an "outperform" rating and a $16.50 price target on the stock.This represents a 6.9% downside from the current price of $17.72. Read More.
- Agiliti (NYSE:AGTI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $43.00 price target on the stock.This represents a 142.7% upside from the current price of $17.72. Read More.
- Agiliti (NYSE:AGTI) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $18.00 price target on the stock.This represents a 1.6% upside from the current price of $17.72. Read More.
- Agiliti (NYSE:AGTI) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $21.00 price target on the stock.This represents a 18.5% upside from the current price of $17.72. Read More.
- Agiliti (NYSE:AGTI) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $18.00 price target on the stock.This represents a 1.6% upside from the current price of $17.72. Read More.
- Agiliti (NYSE:AGTI) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $20.00 price target on the stock.This represents a 12.9% upside from the current price of $17.72. Read More.
- Agiliti (NYSE:AGTI) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $21.00 price target on the stock.This represents a 18.5% upside from the current price of $17.72. Read More.
- Agiliti (NYSE:AGTI) is now covered by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell. They set a "buy" rating and a $19.00 price target on the stock.This represents a 7.2% upside from the current price of $17.72. Read More.
- Agiliti (NYSE:AGTI) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $16.00 price target on the stock.This represents a 9.7% downside from the current price of $17.72. Read More.
- Allakos (NASDAQ:ALLK) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $230.00 price target on the stock.This represents a 127.0% upside from the current price of $101.30. Read More.
- Anthem (NYSE:ANTM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $460.00 price target on the stock.This represents a 16.3% upside from the current price of $395.45. Read More.
- Apollo Endosurgery (NASDAQ:APEN) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $12.00 price target on the stock.This represents a 68.8% upside from the current price of $7.11. Read More.
- Apria (NYSE:APR) is now covered by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell. They set a "buy" rating and a $33.00 price target on the stock.This represents a 0.6% downside from the current price of $33.20. Read More.
- Arena Pharmaceuticals (NASDAQ:ARNA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $90.00 price target on the stock.This represents a 44.0% upside from the current price of $62.51. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at Truist Securities. They set a "buy" rating and a $15.00 price target on the stock.This represents a 27.7% upside from the current price of $11.75. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at Truist. They set a "buy" rating and a $15.00 price target on the stock.This represents a 27.7% upside from the current price of $11.75. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $20.00 price target on the stock.This represents a 70.2% upside from the current price of $11.75. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $15.00 price target on the stock.This represents a 27.7% upside from the current price of $11.75. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $13.50 price target on the stock.This represents a 14.9% upside from the current price of $11.75. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $16.00 price target on the stock.This represents a 36.2% upside from the current price of $11.75. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $16.00 price target on the stock.This represents a 36.2% upside from the current price of $11.75. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $14.00 price target on the stock.This represents a 19.1% upside from the current price of $11.75. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock.This represents a 27.7% upside from the current price of $11.75. Read More.
- Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $17.00 price target on the stock.This represents a 44.7% upside from the current price of $11.75. Read More.
- BioNTech (NASDAQ:BNTX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $173.00 price target on the stock.This represents a 11.2% downside from the current price of $194.88. Read More.
- CASI Pharmaceuticals (NASDAQ:CASI) is now covered by analysts at BTIG Research. They set a "buy" rating and a $4.00 price target on the stock.This represents a 158.9% upside from the current price of $1.55. Read More.
- Colony Bankcorp (NASDAQ:CBAN) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $22.00 price target on the stock.This represents a 16.1% upside from the current price of $18.95. Read More.
- Cigna (NYSE:CI) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $284.00 price target on the stock.This represents a 8.0% upside from the current price of $262.97. Read More.
- Centene (NYSE:CNC) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $87.00 price target on the stock.This represents a 17.3% upside from the current price of $74.16. Read More.
- Coinbase Global (NASDAQ:COIN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $306.00 price target on the stock.This represents a 35.2% upside from the current price of $226.35. Read More.
- CVS Health (NYSE:CVS) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $89.00 price target on the stock.This represents a 1.5% downside from the current price of $90.31. Read More.
- Denali Therapeutics (NASDAQ:DNLI) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $70.00 price target on the stock.This represents a 16.8% upside from the current price of $59.92. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at Loop Capital. They set a "buy" rating and a $40.00 price target on the stock.This represents a 28.1% upside from the current price of $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at Truist Securities. They set a "hold" rating and a $30.00 price target on the stock.This represents a 3.9% downside from the current price of $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $40.00 price target on the stock.This represents a 28.1% upside from the current price of $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at Canaccord Genuity. They set a "buy" rating and a $40.00 price target on the stock.This represents a 28.1% upside from the current price of $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $37.00 price target on the stock.This represents a 18.5% upside from the current price of $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $47.00 price target on the stock.This represents a 50.5% upside from the current price of $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $36.00 price target on the stock.This represents a 15.3% upside from the current price of $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $40.00 price target on the stock.This represents a 28.1% upside from the current price of $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $41.00 price target on the stock.This represents a 31.3% upside from the current price of $31.22. Read More.
- DoubleVerify (NYSE:DV) is now covered by analysts at KeyCorp. They set a "sector weight" rating on the stock.The current price is $31.22. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $33.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell. They set a "neutral" rating and a $34.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $37.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $30.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $29.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $35.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $40.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $34.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $36.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $30.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $33.00 price target on the stock. Read More.
- Endeavor Group (NYSE:EDR) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $35.00 price target on the stock. Read More.
- Ford Motor (NYSE:F) is now covered by analysts at Tudor Pickering. They set a "buy" rating and a $17.00 price target on the stock.This represents a 29.8% upside from the current price of $13.10. Read More.
- F-star Therapeutics (NASDAQ:FSTX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $35.00 price target on the stock.This represents a 343.0% upside from the current price of $7.90. Read More.
- FTC Solar (NASDAQ:FTCI) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $12.00 price target on the stock.This represents a 29.9% upside from the current price of $9.24. Read More.
- FTC Solar (NASDAQ:FTCI) is now covered by analysts at Cowen Inc. They set an "outperform" rating and a $13.00 price target on the stock.This represents a 40.7% upside from the current price of $9.24. Read More.
- FTC Solar (NASDAQ:FTCI) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $11.00 price target on the stock.This represents a 19.0% upside from the current price of $9.24. Read More.
- FTC Solar (NASDAQ:FTCI) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $13.00 price target on the stock.This represents a 40.7% upside from the current price of $9.24. Read More.
- FTC Solar (NASDAQ:FTCI) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $23.00 price target on the stock.This represents a 148.9% upside from the current price of $9.24. Read More.
- FTC Solar (NASDAQ:FTCI) is now covered by analysts at Roth Capital. They set a "buy" rating and a $15.00 price target on the stock.This represents a 62.3% upside from the current price of $9.24. Read More.
- FTC Solar (NASDAQ:FTCI) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $13.00 price target on the stock.This represents a 40.7% upside from the current price of $9.24. Read More.
- General Motors (NYSE:GM) (TSE:GMM.U) is now covered by analysts at Tudor Pickering. They set a "buy" rating and a $76.00 price target on the stock.This represents a 34.0% upside from the current price of $56.70. Read More.
- GT Biopharma (OTCMKTS:GTBP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $25.00 price target on the stock.This represents a 74.1% upside from the current price of $14.36. Read More.
- Halozyme Therapeutics (NASDAQ:HALO) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $56.00 price target on the stock.This represents a 32.0% upside from the current price of $42.41. Read More.
- Humana (NYSE:HUM) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $472.00 price target on the stock.This represents a 5.8% upside from the current price of $445.95. Read More.
- Impel NeuroPharma (NASDAQ:IMPL) is now covered by analysts at Guggenheim. They set a "buy" rating and a $32.00 price target on the stock.This represents a 134.4% upside from the current price of $13.65. Read More.
- Impel NeuroPharma (NASDAQ:IMPL) is now covered by analysts at Wedbush. They set an "outperform" rating and a $21.00 price target on the stock.This represents a 53.8% upside from the current price of $13.65. Read More.
- InMode (NASDAQ:INMD) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $94.00 price target on the stock.This represents a 15.4% upside from the current price of $81.45. Read More.
- KnowBe4 (NASDAQ:KNBE) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $25.00 price target on the stock.This represents a 40.8% upside from the current price of $17.75. Read More.
- KnowBe4 (NASDAQ:KNBE) is now covered by analysts at Canaccord Genuity. They set a "buy" rating and a $26.00 price target on the stock.This represents a 46.5% upside from the current price of $17.75. Read More.
- KnowBe4 (NASDAQ:KNBE) is now covered by analysts at Truist Securities. They set a "buy" rating and a $25.00 price target on the stock.This represents a 40.8% upside from the current price of $17.75. Read More.
- KnowBe4 (NASDAQ:KNBE) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $21.00 price target on the stock.This represents a 18.3% upside from the current price of $17.75. Read More.
- KnowBe4 (NASDAQ:KNBE) is now covered by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell. They set a "neutral" rating and a $21.00 price target on the stock.This represents a 18.3% upside from the current price of $17.75. Read More.
- KnowBe4 (NASDAQ:KNBE) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $21.00 price target on the stock.This represents a 18.3% upside from the current price of $17.75. Read More.
- KnowBe4 (NASDAQ:KNBE) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $24.00 price target on the stock.This represents a 35.2% upside from the current price of $17.75. Read More.
- KnowBe4 (NASDAQ:KNBE) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $24.00 price target on the stock.This represents a 35.2% upside from the current price of $17.75. Read More.
- Karat Packaging (NASDAQ:KRT) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $17.80. Read More.
- The Lion Electric (NYSE:LEV) is now covered by analysts at National Bank of Canada. They set an "outperform" rating and a $20.00 price target on the stock.This represents a 5.5% upside from the current price of $18.96. Read More.
- aTyr Pharma (NASDAQ:LIFE) is now covered by analysts at Jonestrading. They set a "buy" rating and a $15.00 price target on the stock.This represents a 242.5% upside from the current price of $4.38. Read More.
- Mustang Bio (NASDAQ:MBIO) is now covered by analysts at BTIG Research. They set a "buy" rating and a $11.00 price target on the stock.This represents a 239.5% upside from the current price of $3.24. Read More.
- Magenta Therapeutics (NASDAQ:MGTA) is now covered by analysts at B. Riley. They set a "buy" rating and a $21.00 price target on the stock.This represents a 81.3% upside from the current price of $11.58. Read More.
- Molina Healthcare (NYSE:MOH) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating and a $253.00 price target on the stock.This represents a 1.1% downside from the current price of $255.90. Read More.
- NeuroPace (NASDAQ:NPCE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $27.00 price target on the stock.This represents a 18.2% upside from the current price of $22.85. Read More.
- NeuroPace (NASDAQ:NPCE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $25.00 price target on the stock.This represents a 9.4% upside from the current price of $22.85. Read More.
- NeuroPace (NASDAQ:NPCE) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $26.00 price target on the stock.This represents a 13.8% upside from the current price of $22.85. Read More.
- NeuroPace (NASDAQ:NPCE) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $25.00 price target on the stock.This represents a 9.4% upside from the current price of $22.85. Read More.
- Omnicell (NASDAQ:OMCL) is now covered by analysts at BTIG Research. They set a "buy" rating and a $165.00 price target on the stock.This represents a 19.6% upside from the current price of $137.99. Read More.
- Onconova Therapeutics (NASDAQ:ONTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $4.00 price target on the stock.This represents a 52.1% downside from the current price of $8.35. Read More.
- Opendoor Technologies (NASDAQ:OPEN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $17.00 price target on the stock.This represents a 13.6% upside from the current price of $14.96. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $71.00 price target on the stock.This represents a 19.3% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $80.00 price target on the stock.This represents a 9.1% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "market perform" rating on the stock.The current price is $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $75.00 price target on the stock.This represents a 14.8% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $85.00 price target on the stock.This represents a 3.4% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $70.00 price target on the stock.This represents a 20.4% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Royal Bank of Canada. They set a "sector perform" rating and a $74.00 price target on the stock.This represents a 15.9% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at DA Davidson. They set a "buy" rating and a $85.00 price target on the stock.This represents a 3.4% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Wolfe Research. They set a "peer perform" rating and a $70.00 price target on the stock.This represents a 20.4% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Canaccord Genuity. They set a "hold" rating and a $70.00 price target on the stock.This represents a 20.4% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $68.00 price target on the stock.This represents a 22.7% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Mizuho. They set a "buy" rating and a $77.00 price target on the stock.This represents a 12.5% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Truist Securities. They set a "buy" rating and a $80.00 price target on the stock.This represents a 9.1% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $85.00 price target on the stock.This represents a 3.4% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Macquarie. They set a "neutral" rating and a $69.00 price target on the stock.This represents a 21.6% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $82.00 price target on the stock.This represents a 6.8% downside from the current price of $87.99. Read More.
- UiPath (NASDAQ:PATH) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $72.00 price target on the stock.This represents a 18.2% downside from the current price of $87.99. Read More.
- PureCycle Technologies (NYSE:PCT) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $24.00 price target on the stock.This represents a 41.2% upside from the current price of $17.00. Read More.
- Pool (NASDAQ:POOL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $535.00 price target on the stock.This represents a 24.4% upside from the current price of $430.08. Read More.
- Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Truist Securities. They set a "buy" rating and a $40.00 price target on the stock.This represents a 23.6% upside from the current price of $32.35. Read More.
- Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $44.00 price target on the stock.This represents a 36.0% upside from the current price of $32.35. Read More.
- Privia Health Group (NASDAQ:PRVA) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $32.35. Read More.
- Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Canaccord Genuity. They set a "buy" rating and a $47.00 price target on the stock.This represents a 45.3% upside from the current price of $32.35. Read More.
- Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Truist. They set a "buy" rating and a $40.00 price target on the stock.This represents a 23.6% upside from the current price of $32.35. Read More.
- Privia Health Group (NASDAQ:PRVA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $40.00 price target on the stock.This represents a 23.6% upside from the current price of $32.35. Read More.
- Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $40.00 price target on the stock.This represents a 23.6% upside from the current price of $32.35. Read More.
- Poseida Therapeutics (NASDAQ:PSTX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $40.00 price target on the stock.This represents a 353.5% upside from the current price of $8.82. Read More.
- Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $42.00 price target on the stock.This represents a 17.6% upside from the current price of $35.70. Read More.
- Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $48.00 price target on the stock.This represents a 34.5% upside from the current price of $35.70. Read More.
- Rain Therapeutics (NASDAQ:RAIN) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $25.00 price target on the stock.This represents a 50.1% upside from the current price of $16.66. Read More.
- Rain Therapeutics (NASDAQ:RAIN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $56.00 price target on the stock.This represents a 236.1% upside from the current price of $16.66. Read More.
- Rain Therapeutics (NASDAQ:RAIN) is now covered by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell. They set a "buy" rating and a $28.00 price target on the stock.This represents a 68.1% upside from the current price of $16.66. Read More.
- Rain Therapeutics (NASDAQ:RAIN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $26.00 price target on the stock.This represents a 56.1% upside from the current price of $16.66. Read More.
- RedHill Biopharma (NASDAQ:RDHL) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $23.00 price target on the stock.This represents a 226.2% upside from the current price of $7.05. Read More.
- Reata Pharmaceuticals (NASDAQ:RETA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $236.00 price target on the stock.This represents a 106.7% upside from the current price of $114.19. Read More.
- Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $49.00 price target on the stock.This represents a 57.0% upside from the current price of $31.22. Read More.
- Seagen (NASDAQ:SGEN) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $153.00 price target on the stock.This represents a 1.6% downside from the current price of $155.43. Read More.
- SkyWater Technology (NASDAQ:SKYT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $27.00 price target on the stock.This represents a 0.9% upside from the current price of $26.75. Read More.
- SkyWater Technology (NASDAQ:SKYT) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $25.00 price target on the stock.This represents a 6.5% downside from the current price of $26.75. Read More.
- Stem (NYSE:STEM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $30.00 price target on the stock.This represents a 27.9% upside from the current price of $23.45. Read More.
- Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $35.00 price target on the stock.This represents a 5.3% downside from the current price of $36.94. Read More.
- Surface Oncology (NASDAQ:SURF) is now covered by analysts at BTIG Research. They set a "buy" rating and a $17.00 price target on the stock.This represents a 92.3% upside from the current price of $8.84. Read More.
- Latham Group (NASDAQ:SWIM) is now covered by analysts at Truist Securities. They set a "buy" rating and a $37.00 price target on the stock.This represents a 27.1% upside from the current price of $29.11. Read More.
- Latham Group (NASDAQ:SWIM) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $38.00 price target on the stock.This represents a 30.5% upside from the current price of $29.11. Read More.
- Latham Group (NASDAQ:SWIM) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $38.00 price target on the stock.This represents a 30.5% upside from the current price of $29.11. Read More.
- Latham Group (NASDAQ:SWIM) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $36.00 price target on the stock.This represents a 23.7% upside from the current price of $29.11. Read More.
- Latham Group (NASDAQ:SWIM) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $37.00 price target on the stock.This represents a 27.1% upside from the current price of $29.11. Read More.
- Latham Group (NASDAQ:SWIM) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $29.11. Read More.
- Latham Group (NASDAQ:SWIM) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $33.00 price target on the stock.This represents a 13.4% upside from the current price of $29.11. Read More.
- Latham Group (NASDAQ:SWIM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $26.00 price target on the stock.This represents a 10.7% downside from the current price of $29.11. Read More.
- Treace Medical Concepts (NASDAQ:TMCI) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $35.00 price target on the stock.This represents a 20.0% upside from the current price of $29.16. Read More.
- Treace Medical Concepts (NASDAQ:TMCI) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $30.00 price target on the stock.This represents a 2.9% upside from the current price of $29.16. Read More.
- Treace Medical Concepts (NASDAQ:TMCI) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $37.00 price target on the stock.This represents a 26.9% upside from the current price of $29.16. Read More.
- Treace Medical Concepts (NASDAQ:TMCI) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $38.00 price target on the stock.This represents a 30.3% upside from the current price of $29.16. Read More.
- TS Innovation Acquisitions (NASDAQ:TSIA) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $16.00 price target on the stock.This represents a 57.5% upside from the current price of $10.16. Read More.
- Tesla (NASDAQ:TSLA) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $590.00 price target on the stock.This represents a 0.9% downside from the current price of $595.60. Read More.
- UnitedHealth Group (NYSE:UNH) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $478.00 price target on the stock.This represents a 15.7% upside from the current price of $413.13. Read More.
- Vaccitech (NASDAQ:VACC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $25.00 price target on the stock.This represents a 71.5% upside from the current price of $14.58. Read More.
- Zymergen (NASDAQ:ZY) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $40.00 price target on the stock.This represents a 13.8% upside from the current price of $35.15. Read More.
- Zymergen (NASDAQ:ZY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $55.00 price target on the stock.This represents a 56.5% upside from the current price of $35.15. Read More.
- View today's most recent analysts' new coverage at MarketBeat.com
| More Calendars from MarketBeat | | U.S. Analyst Ratings, Canadian Analyst Ratings, U.K. Analyst Ratings, Corporate Buybacks, Cryptocurrencies, Dividend Declarations, Earnings Announcements, Earnings Conference Calls, Economic Reports, Gap Up/Down Stocks, Insider Trades, Initial Public Offerings (IPOs), Most Active Stocks, Percentage Gainers/Decliners, Sector Performance, Short Interest, Stock Splits, Unusual Options Volume & Unusual Trading Volume. |
| Upgrade Your Subscription |
Upgrade to MarketBeat Daily Premium and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW  |
|
|
View and add up to five holdings to your watchlist.
| VIEW MY PORTFOLIO |
|
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
| JOIN NOW |
|
|
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257. |
Tidak ada komentar:
Posting Komentar